Series A funding round for Ambys Medicines raising $60M in August 2018
Series A funding round for Ambys Medicines raising $60M in August 2018
| Investor | Firm Type | Partner |
|---|
Takeda VenturesLEAD | Venture Capital | — |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$107M
Top Valuation
-
Ambys Medicines raised $60M in a Series A round.
The round was announced on 08/01/18.
The round was led by Third Rock Ventures, Asit Parikh.